UNIVERSITY OF WASHINGTON

Jessie Owen, who sustained a spinal cord injury 12 years ago, has regained hand function using the ARC-EX spinal cord stimulator. Approved by the FDA and first used at Harborview Medical Center, this device, likened to a hearing aid for the spinal cord, facilitates movement by enhancing communication between sensory and motor nerves, offering hope for improved mobility over time.

Nancy Whiting, Pharm.D., is the president and CEO of Recludix Pharma, with a significant background at Seagen, contributing to the development of several cancer treatments. She also serves on the boards of Caribou BioSciences and Boundless BioSciences. Biocom California advocates for the life science sector, supporting over 1,800 members to innovate and improve human health.

A Washington nonprofit trains pharmacists to prescribe abortion meds via telehealth, aiming to expand access. The Pharmacist Abortion Access Project, with Honeybee Health, trained 10 pharmacists to prescribe FDA-approved meds up to 10 weeks' gestation. Despite opposition, research supports telehealth's safety. The pilot successfully prescribed meds to 43, with plans to expand. Washington's progressive pharmacy laws contrast with Idaho's strict abortion bans.

Oncocyte Corp. appoints Dr. Paul Billings as Consulting Chief Medical Officer. With over 40 years in genomics and precision medicine, Dr. Billings aims to enhance clinical utility and patient care accessibility. His expertise spans academia, government, and biotech, including roles at Biological Dynamics and Natera, Inc.

Oncocyte appoints Dr. Paul Billings as Consulting Chief Medical Officer. With over 40 years in genomics and precision medicine, Dr. Billings will support strategic and clinical goals, regulatory and reimbursement support, and business development. His expertise aims to bridge clinical innovation with accessible care.

Sugar-sweetened beverages (SSB) are linked to over 2 million new type 2 diabetes and 1.2 million heart disease cases annually worldwide. High consumption in countries like Colombia, Mexico, and South Africa exacerbates health issues. Urgent interventions, including soda taxes and public health campaigns, are needed to reduce SSB consumption and its health impacts.

Oncocyte appoints Dr. Paul Billings as Consulting Chief Medical Officer, leveraging his extensive experience in genomics and precision medicine to advance the company's diagnostic technologies and patient care initiatives.

A Washington nonprofit trains pharmacists to prescribe abortion meds via telehealth, aiming to expand access. Despite legal abortion up to 24-26 weeks, barriers exist. The program, involving 10 pharmacists, prescribes FDA-approved meds up to 10 weeks' gestation, with follow-ups. Research supports telehealth safety. The pilot successfully served 43, with plans to expand. Washington's progressive pharmacy laws contrast with Idaho's strict abortion bans.

Washington leads with a lenient policy allowing pharmacists to prescribe mifepristone for abortion, with a pilot showing 43 patients received prescriptions. Other states may follow, despite 15 having restrictions. Washington's approach requires only doctor-approved protocols and training, with no serious negative outcomes reported.